BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Meara SJ, Rodgers K, Godson C. Lipoxins: update and impact of endogenous pro-resolution lipid mediators. Rev Physiol Biochem Pharmacol 2008;160:47-70. [PMID: 18481030 DOI: 10.1007/112_2006_0606] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Zheng S, Wang Q, He Q, Song X, Ye D, Gao F, Jin S, Lian Q. Novel biphasic role of LipoxinA(4) on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts. Mediators Inflamm 2011;2011:745340. [PMID: 21765620 DOI: 10.1155/2011/745340] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
2 Chávez-Castillo M, Ortega Á, Cudris-Torres L, Duran P, Rojas M, Manzano A, Garrido B, Salazar J, Silva A, Rojas-Gomez DM, De Sanctis JB, Bermúdez V. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy? Int J Mol Sci 2021;22:10370. [PMID: 34638711 DOI: 10.3390/ijms221910370] [Reference Citation Analysis]
3 Carranza C, Carreto-binaghi LE, Guzmán-beltrán S, Muñoz-torrico M, Torres M, González Y, Juárez E. Sex-Dependent Differential Expression of Lipidic Mediators Associated with Inflammation Resolution in Patients with Pulmonary Tuberculosis. Biomolecules 2022;12:490. [DOI: 10.3390/biom12040490] [Reference Citation Analysis]
4 He M, Cheng N, Gao WW, Zhang M, Zhang YY, Ye RD, Wang MW. Characterization of Quin-C1 for its anti-inflammatory property in a mouse model of bleomycin-induced lung injury. Acta Pharmacol Sin 2011;32:601-10. [PMID: 21499285 DOI: 10.1038/aps.2011.4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
5 Huang LS, Hung ND, Sok DE, Kim MR. Lysophosphatidylcholine containing docosahexaenoic acid at the sn-1 position is anti-inflammatory. Lipids 2010;45:225-36. [PMID: 20165929 DOI: 10.1007/s11745-010-3392-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
6 Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, Parmentier M, Serhan CN, Murphy PM. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 2009;61:119-61. [PMID: 19498085 DOI: 10.1124/pr.109.001578] [Cited by in Crossref: 482] [Cited by in F6Publishing: 477] [Article Influence: 37.1] [Reference Citation Analysis]
7 Ward JR, Wilson HL, Francis SE, Crossman DC, Sabroe I. Translational mini-review series on immunology of vascular disease: inflammation, infections and Toll-like receptors in cardiovascular disease. Clin Exp Immunol. 2009;156:386-394. [PMID: 19309349 DOI: 10.1111/j.1365-2249.2009.03886.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
8 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
9 Wang Q, Yan SF, Hao Y, Jin SW. Specialized Pro-resolving Mediators Regulate Alveolar Fluid Clearance during Acute Respiratory Distress Syndrome. Chin Med J (Engl) 2018;131:982-9. [PMID: 29664060 DOI: 10.4103/0366-6999.229890] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
10 Yang Y, Cheng Y, Lian QQ, Yang L, Qi W, Wu DR, Zheng X, Liu YJ, Li WJ, Jin SW, Smith FG. Contribution of CFTR to alveolar fluid clearance by lipoxin A4 via PI3K/Akt pathway in LPS-induced acute lung injury. Mediators Inflamm 2013;2013:862628. [PMID: 23766562 DOI: 10.1155/2013/862628] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
11 Chakrabarti SK, Cole BK, Wen Y, Keller SR, Nadler JL. 12/15-lipoxygenase products induce inflammation and impair insulin signaling in 3T3-L1 adipocytes. Obesity (Silver Spring). 2009;17:1657-1663. [PMID: 19521344 DOI: 10.1038/oby.2009.192] [Cited by in Crossref: 97] [Cited by in F6Publishing: 98] [Article Influence: 7.5] [Reference Citation Analysis]
12 He HQ, Ye RD. The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition. Molecules 2017;22:E455. [PMID: 28335409 DOI: 10.3390/molecules22030455] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 20.2] [Reference Citation Analysis]